Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 17,300 More Arrow 21,515 Less Arrow 5,178
Financial expenses 3,136 Less Arrow 1,673 Less Arrow 206
Earnings before taxes -22,063 Less Arrow -29,022 More Arrow -15,143
EBITDA -15,918 Less Arrow -27,105 More Arrow -14,268
Total assets 73,341 Less Arrow 58,896 More Arrow 62,050
Current assets 52,749 Less Arrow 41,609 More Arrow 46,146
Current liabilities 46,832 Less Arrow 29,430 Less Arrow 21,258
Equity capital 18,155 Less Arrow 15,441 More Arrow 38,181
- share capital 29,904 Less Arrow 602 Less Arrow 554
Employees (average) 71 More Arrow 89 Less Arrow 68

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 24.8% More Arrow 26.2% More Arrow 61.5%
Turnover per employee 244 Less Arrow 242 Less Arrow 76
Profit as a percentage of turnover -127.5% Less Arrow -134.9% Less Arrow -292.4%
Return on assets (ROA) -25.8% Less Arrow -46.4% More Arrow -24.1%
Current ratio 112.6% More Arrow 141.4% More Arrow 217.1%
Return on equity (ROE) -121.5% Less Arrow -188.0% More Arrow -39.7%
Change turnover -3,483 More Arrow 16,322 Less Arrow 5,178
Change turnover % -17% More Arrow 314%
Chg. No. of employees -18 More Arrow 21 Less Arrow 18
Chg. No. of employees % -20% More Arrow 31% More Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.